Primary prevention of cardiovascular events by ASS and vitamin E. PPP--Primary Prevention Project
Nordt, T.
Der Internist 42(12): 1705-1707
2001
ISSN/ISBN: 0020-9554 PMID: 11793610 Document Number: 527152
Document emailed within 1 workday
Related Documents
De Caterina, R. 2001: The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 2(6): 681-684Guo, Y.F. 2019: Effects of aspirin on primary prevention of cardiovascular events in patients with hypertension Zhonghua Nei Ke Za Zhi 58(4): 249-251
Klomp, C.M.C.; ten Cate, H.; Stehouwer, C.D.A.; Schaper, N.C. 2009: Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events Nederlands Tijdschrift Voor Geneeskunde 153: A109
Iavelov, I.S. 2006: Aspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials) Kardiologiia 46(3): 75-76
Garrett, R.E. 1986: Primary prevention of cardiovascular disease Journal of Family Practice 22(3): 222 224
Mutter, J.; Grandy, R.; Hulkower, S.; Stigleman, S. 2018: Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events? Journal of Family Practice 67(4): 247-248
Onder, L.; Nicolosi, G.Luigi. 2010: The primary role of cardiologists in cardiovascular prevention Giornale Italiano di Cardiologia 11(5 Suppl. 3): 131s-132s
Miser, W.Fred. 2011: Appropriate aspirin use for primary prevention of cardiovascular disease American Family Physician 83(12): 1380-1386
Chazov, E.I. 2002: Problems in primary and secondary prevention of cardiovascular diseases Terapevticheskii Arkhiv 74(9): 5-8
Brohet, C. 1995: Risk factors and primary prevention of cardiovascular disease Journal de Pharmacie de Belgique 50(1): 20-24
García-Palmieri, M.R. 2000: Primary and secondary prevention of cardiovascular disease in the elderly Boletin de la Asociacion Medica de Puerto Rico 92(1-3): 3-8
Béliard-Lasserre, S. 2016: Should we prescribe statins for primary prevention of cardiovascular risk? Rather yes La Revue du Praticien 66(3): 332-334
Volpe, M.; Tocci, G. 2012: Global cardiovascular risk management in primary prevention Current Vascular Pharmacology 10(6): 709-711
Sobieszczańska, Młgorzata.; Kałka, D.; Pilecki, W.; Adamus, J. 2009: Physical activity in basic and primary prevention of cardiovascular disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 26(156): 659-664
Tkacheva, O.N.; Sharashkina, N.V. 2010: Possibilities of ramipril in primary and secondary prevention of cardiovascular diseases Kardiologiia 50(8): 63-66
Fretheim, A.; Bjørndal, A.; Oxman, A.D.; Dyrdal, A.; Golding, M.; Ose, L.; Reikvam, A.; Teisberg, P. 2002: Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 122(23): 2287-2288
Richard, J.L.; Delahaye, F. 1998: Cardiovascular prevention, primary or secondary, in high risk patients Archives des Maladies du Coeur et des Vaisseaux 91(12): 1495-1502
Schlierf, G. 1980: Primary and secondary prevention of cardiovascular diseases - metabolic aspects Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 546-550
Nanchen, D.; Chiolero, A.; Marques-Vidal, P-Manuel.; Cornuz, J.; Waeber, Gérard.; Vollenweider, P.; Rodondi, N. 2010: Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland? Revue Medicale Suisse 6(239): 488-90 492-3
Hovens, M.M.C.; Cannegieter, S.C. 2004: Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease Nederlands Tijdschrift Voor Geneeskunde 148(42): 2097; Author Reply 2097-8